Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long‐term open‐label safety extension study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long‐term open‐label safety extension study
Authors
Keywords
-
Journal
EPILEPSIA
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-08-28
DOI
10.1111/epi.16638
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial
- (2019) Lieven Lagae et al. LANCET
- Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens
- (2019) Rima Nabbout et al. JAMA Neurology
- Assessing the impact of caring for a child with Dravet syndrome: Results of a caregiver survey
- (2018) Jonathan D. Campbell et al. EPILEPSY & BEHAVIOR
- A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a regimen of stiripentol, clobazam, and valproate in healthy subjects
- (2018) Brooks Boyd et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- The humanistic and economic burden of Dravet syndrome on caregivers and families: Implications for future research
- (2017) Mark P. Jensen et al. EPILEPSY & BEHAVIOR
- Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation
- (2017) William A. Zoghbi et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
- (2016) Igho J. Onakpoya et al. CRITICAL REVIEWS IN TOXICOLOGY
- Five-year extended follow-up status of 10 patients with Dravet syndrome treated with fenfluramine
- (2016) Berten Ceulemans et al. EPILEPSIA
- Mortality in Dravet syndrome: A review
- (2016) Sharon Shmuely et al. EPILEPSY & BEHAVIOR
- Mortality in Dravet syndrome
- (2016) Monica S. Cooper et al. EPILEPSY RESEARCH
- Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients
- (2016) A. Schoonjans et al. EUROPEAN JOURNAL OF NEUROLOGY
- Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension
- (2016) James D. West et al. PLoS One
- The European patient with Dravet syndrome: Results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome
- (2015) Luis Miguel Aras et al. EPILEPSY & BEHAVIOR
- Valvular Regurgitation Using Portable Echocardiography in a Healthy Student Population: Implications for Rheumatic Heart Disease Screening
- (2015) Rachel H. Webb et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome
- (2015) An-Sofie Schoonjans et al. Therapeutic Advances in Neurological Disorders
- Echocardiography in Pediatric Pulmonary Hypertension
- (2014) Pei-Ni Jone et al. Frontiers in Pediatrics
- Successful use of fenfluramine as an add-on treatment for Dravet syndrome
- (2012) Berten Ceulemans et al. EPILEPSIA
- The core Dravet syndrome phenotype
- (2011) Charlotte Dravet EPILEPSIA
- Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals
- (2008) Charles F Dahl et al. BMC Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started